Discover the complete record of transactions filed by 김동건, Directeur. Officer active across 2 companies, notably 카나프테라퓨틱스. Cumulatively, 17,943 reports have been recorded. History available since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Kim Dong-geon is a director at Kanaf Therapeutics, a company specializing in innovative therapies. He is responsible for managing operations and developing new treatments. His expertise is essential for the company's success in the market.